GENTAFAIR Drug Patent Profile
✉ Email this page to a colleague
When do Gentafair patents expire, and when can generic versions of Gentafair launch?
Gentafair is a drug marketed by Pharmafair and is included in five NDAs.
The generic ingredient in GENTAFAIR is gentamicin sulfate. There are fifteen drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the gentamicin sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Gentafair
A generic version of GENTAFAIR was approved as gentamicin sulfate by SANDOZ on December 31st, 1969.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for GENTAFAIR?
- What are the global sales for GENTAFAIR?
- What is Average Wholesale Price for GENTAFAIR?
Summary for GENTAFAIR
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 5 |
Raw Ingredient (Bulk) Api Vendors: | 34 |
DailyMed Link: | GENTAFAIR at DailyMed |
US Patents and Regulatory Information for GENTAFAIR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pharmafair | GENTAFAIR | gentamicin sulfate | CREAM;TOPICAL | 062458-001 | Sep 1, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Pharmafair | GENTAFAIR | gentamicin sulfate | OINTMENT;TOPICAL | 062444-001 | May 26, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Pharmafair | GENTAFAIR | gentamicin sulfate | INJECTABLE;INJECTION | 062493-001 | Aug 28, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Pharmafair | GENTAFAIR | gentamicin sulfate | OINTMENT;OPHTHALMIC | 062443-001 | May 26, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |